Parnax Lab Balance Sheet Annual

Trade

BSE: 506128 | NSE: - | ISIN: INE383L01019 | Sector: Biotechnology & Drugs

161.60 -0.80 (-0.49%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	0.46	1.28	4.36	0.18
Cash Equivalents	1.42	-	1.42	1.08
Cashand Short Term Investments	1.88	1.28	5.78	1.27
Accounts Receivable- Trade Net	32.56	27.89	38.08	16.71
Total Receivables Net	33.67	31.39	39.27	20.17
Total Inventory	29.93	21.77	19.93	10.79
Other Current Assets Total	9.96	6.62	9.79	7.02
Total Current Assets	75.43	61.06	74.77	39.24
Property/ Plant/ Equipment Total- Net	100.79	78.90	75.20	64.43
Intangibles Net	9.31	0.23	0.09	0.14
Long Term Investments	0.84	0.16	0.76	0.74
Other Long Term Assets Total	2.40	0.58	2.64	1.71
Total Assets	188.77	145.07	153.46	106.26
Accounts Payable	22.18	22.24	22.08	6.23
Current Portof LT Debt/ Capital Leases	50.70	6.11	5.81	5.34
Other Currentliabilities Total	8.95	1.14	10.39	6.37
Total Current Liabilities	81.83	63.04	80.98	54.37
Long Term Debt	21.05	11.38	16.49	13.75
Capital Lease Obligations	8.89	3.95	4.07	3.38
Total Long Term Debt	29.94	15.33	20.57	17.13
Total Debt	80.64	54.72	69.07	58.90
Deferred Income Tax	4.69	3.93	3.17	1.87
Minority Interest	0.12	0.11	0.09	0.08
Other Liabilities Total	0.61	0.51	0.47	0.26
Total Liabilities	117.19	82.92	105.28	73.71
Common Stock Total	11.49	11.49	9.81	8.50
Retained Earnings( Accumulated Deficit)	60.09	40.82	38.37	24.04
Total Equity	71.57	62.15	48.19	32.54
Total Liabilities Shareholders' Equity	188.77	145.07	153.46	106.26
Total Common Shares Outstanding	1.15	1.15	0.98	0.85
Tangible Book Valueper Share Common Eq	54.21	53.91	49.00	38.10
Property/ Plant/ Equipment Total- Gross	-	109.74	3.34	4.91
Accumulated Depreciation Total	-	-30.84	-	-
Note Receivable- Long Term	-	4.13	-	-
Accrued Expenses	-	0.28	-	-
Notes Payable/ Short Term Debt	-	33.27	42.70	36.43
Additional Paid- In Capital	-	9.99	-	-
Other Equity Total	-	-0.14	-	0.00